| Literature DB >> 31007217 |
Chintan Malhotra1, Natasha G Seth1, Surinder S Pandav1, Arun K Jain1, Sushmita Kaushik1, Amit Gupta1, Srishti Raj1, Deepika Dhingra1.
Abstract
Purpose: To evaluate the patient demographics and morphological characteristics of corneal endothelium by in vivo confocal microscopy (IVCM), in patients with Iridocorneal Endothelial (ICE) Syndrome.Entities:
Keywords: Confocal microscopy; Endothelium; Iridocorneal endothelial syndrome
Mesh:
Year: 2019 PMID: 31007217 PMCID: PMC6498939 DOI: 10.4103/ijo.IJO_1237_18
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Figure 1Representative pictures of anterior segment findings seen in patients clinically suspected to have ICE syndrome (a) small patch of iris atrophy (yellow arrow) with slight corectopia (white arrow) (b) multiple patches of iris atrophy with corectopia (c) ectropion uvea with a distorted pupil (d and e) iris atrophy, iris holes and severe corectopia (f) diffuse corneal edema with iris details visible faintly (g) broad PAS seen on gonioscopy (yellow arrow) (h) “hammered silver” appearance of endothelium seen on slit lamp biomicroscopy (white arrow)
Figure 2Representative in vivo confocal microscopy images showing (a) ICE – variant of endothelial cells (large cells with widely spaced yet centrally placed hyperreflective nuclei) (b) ICE + variant of endothelial cells (smaller cells with more tightly packed, eccentrically placed hyper reflective nuclei)
Figure 3Representative in vivo confocal microscopy images showing the variable appearance of the affected endothelium amongst the study patients a and b) “Epitheloid transformation” with prominent hyper reflective nuclei (c) Doubling of nuclei within a cell (red arrow) (d) “light dark reversal” of the endothelial cells with cell bodies appearing dark and cell boundaries appearing brighter (yellow arrows)
The demographic profile, clinical features and in vivo confocal microscopy findings of the study cohort
| Subject | Age/Sex | Eye | Clinical Diagnosis | Clinical features | Endothelial findings on IVCM | ECD in affected eye [cells/mm2] | ECD in uninvolved eye [cells/mm2] | Corneal edema | Raised IOP | Glaucoma severity | Surgery | Antiglaucoma Medicine at final follow-up | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AKJ | 62/F | OU [OD > OS] | Ch | OD- Corneal edema OS-‘ hammered silver appearance’ of endothelium on specular reflection by slit lamp biomicroscopy | OD Total ICE- OS Disseminated ICE cells | OD 1013±24 OS 2514±57 | - | OD Yes OS No | OD – Yes OS - No | 2 | GFS | T-3 | 120 |
| SG | 79/M | OD | PIA | PAS, IA, IH | Total ICE - | 680±26 | 2500±51 | Yes | Yes | 1 | - | T-2 | 72 |
| SK | 43/M | OD | PIA | IA, IH, Ectropion uvea, Corectopia | Total ICE + | 2352±44 | 2800±30 | No | Yes | 3 | GFS | - | 72 |
| GK | 35/F | OD | PIA | PAS, IA, IH, ectropion uvea | Total ICE + | 1827±57 | 2597±59 | Yes | Yes | 3 | GDD | T-4 S-1 | 24 |
| Ba K | 40/F | OD | CR | PAS, corectopia, iris nodules | Total ICE+ | 2133±60 | 2500±50 | No | Yes | 3 | GFS | T-4 S-1 | 24 |
| Ba S | 63/M | OS | PIA | IA, corectopia | Total ICE - | 731±50 | 2807±60 | Yes | Yes | 1 | - | T-3 | 48 |
| BK | 47/M | OS | Ch | Corneal edema | Total ICE - | 931±58 | 2903±63 | Yes | Yes | 1 | - | T-2 | 36 |
| Ma S | 58/M | OS | PIA | PAS, IA | Total ICE - | 1026±56 | 2400±50 | No | Yes | 3 | GFS | - | 84 |
| TG | 27/F | OS | PIA | IA, PAS | Total ICE - | 1053±43 | 2472±66 | No | Yes | 3 | GDD | - | 24 |
| Tu B | 8/M | OD | PIA | PAS, IH | Total ICE - | 1069±39 | 2672±48 | No | No | - | - | - | 3 |
| Arc S | 26/F | OD | PIA | PAS, IH | Total ICE + | 2017±70 | 2578±119 | No | No | - | - | - | 3 |
| Pr B | 53/F | OS | PIA | PAS, IA, IH | Total ICE + | 2252±30 | 3030±68 | Yes | Yes | 2 | GFS | T-4 | 12 |
| Me S | 58/M | OS | PIA | IA, corectopia | Total ICE - | 523±14 | 2253±55 | No | Yes | 3 | GFS, GDD | T-4 S-1 | 24 |
| Bh S | 37/M | OS | PIA | IA, IH | Total ICE - | 1506±33 | 2841±81 | No | Yes | 3 | GFS | T-3 S-1 | 6 |
| Ni | 33/F | OD | PIA | PAS, corectopia | Total ICE - | 1138±25 | 2510±59 | No | Yes | 2 | GFS | T-4 | 12 |
| NKB | 51/M | OD | Ch | Corneal edema | Subtotal ICE - | 2150±47 | 2750±45 | Yes (sectoral) | Yes | 1 | - | - | 2 |
| Aru S | 25/M | OD | PIA | PAS, IA, IH, corectopia | Total ICE - | 1260±26 | 2610±44 | No | Yes | 1 | - | T-1 | 3 |
| Po B | 45/F | OD | PIA | PAS, corectopia | Total ICE+ | 1766±32 | 2201±43 | No | Yes | 2 | GFS | T-1 | 12 |
| SP S | 47/M | OU | OD-Ch OS-Ch | OD- Corneal edema OS- diffuse subepithelial fibrosos. AC details not visualized clearly | OD Total ICE - OS endothelium not visualized due to fibrosis | OD 519±18 OS Could not be visualized | - | OD Yes OS No | Yes | 2 | GFS OU | OD: T-1 OS: T-1 | 132 |
| RS | 46/M | OS | CR | PAS, corectopia, iris nodules | Total ICE- | 2114±56 | 3062±96 | No | Yes | 1 | - | T-2 | 6 |
| RK | 46/M | OS | CR | PAS, IA, Iris nodules | Total ICE - | 1061±18 | 2444±61 | No | Yes | 2 | GDD | T-1 | 12 |
ECD: Endothelial cell density; F: Female; IA: Iris atrophy; IH: Iris hole; IOP: Intraocular pressure; KP: Keratic precipitates; M: Male; OD: Oculus dexter (right eye); OS: Oculus sinister (left eye); OU: Oculus uterque (both eyes); PIA: Progressive Iris Atrophy, Ch: Chandeller Syndrome, CR: Cogan Reese Syndrome; PAS: Peripheral anterior synechiae; GFS: Glaucoma Filteration Surgery; GDD: Glaucoma Drainage Device; T: Topical antiglaucoma medicine, S: Systemic antiglaucoma medicine
Comparison of Demographic and clinical parameters with the studies published in Literature
| Liu | Le | Sherrard | Laganowski | Our study | |
|---|---|---|---|---|---|
| Demographic profile | |||||
| Number of patients | 15 | 12 | 57 | 66 | 21 |
| Age (years) Mean±SD (Range) | 32-72 (54) | 27-64 (44.6) | 19-74 (44) | 19-65 (45) | 8-79 (44.2) |
| Sex (M:F)(%age) | 20:80 | 17:83 | 47:53 | 47:53 | 62:38 |
| Unilateral: bilateral (%age) | 93.33:6.66 | 100:0 | - | 100:0 | 91.5:9.5 |
| Clinical type (%) | |||||
| Chandler syndrome | 73.33% | 33.33% | 32% | 36.36% | 19.05% |
| ICE type (%age) | |||||
| Total | 30.7% | - | 30% | 36.36% | 91% |
| Morphology of cells (%age) | |||||
| ICE -ve | 62.5% | - | 30% | 30% | 70% |
| ICE+ve | 37.5% | - | 70% | 70% | 30% |
| Mean endothelial cell density (cells per mm²) | - | 869.7±85.8 (affected eyes) 2523.6±78.8 (unaffected eyes) | 689-1501 | - | 1446±653 (affected eyes) 2628±239 (unaffected eyes) |
| Glaucoma | |||||
| Prevalence of Glaucoma | 66.66% | 100% | 71% of total ICE group, 18% of subtotal | 50% | 86.4% |
| Requirement of Glaucoma surgery (%) | 53.33 | 91.66 | - | 33.33 | 65.22 |